Lalonde R, Vikis-Freibergs V
Pharmacol Biochem Behav. 1985 Mar;22(3):377-82. doi: 10.1016/0091-3057(85)90035-8.
The activity of 5-HT was manipulated by means of the peripheral injection of 5-HT reuptake inhibitors, fenfluramine and fluoxetine. These drug treatments, at doses higher than 1 mg/kg, produced retrograde amnesia in a one-trial appetitive learning task in rats. A non-specific inhibitor of 5-HT reuptake, imipramine, did not produce this amnesic effect, nor did the combination of fenfluramine with the MAOI tranylcypromine, although it produced, as expected, the "serotonergic syndrome." Results for the metabolic precursor of 5-HT, 5-HTP, also administered peripherally, were inconsistent, with amnesic effects seen at 5 and 20 mg/kg but none at 10 mg/kg.
通过外周注射5-羟色胺(5-HT)再摄取抑制剂芬氟拉明和氟西汀来操控5-HT的活性。这些药物治疗在剂量高于1毫克/千克时,会在大鼠的一次性食欲学习任务中产生逆行性遗忘。5-HT再摄取的非特异性抑制剂丙咪嗪不会产生这种遗忘效应,芬氟拉明与单胺氧化酶抑制剂反苯环丙胺的组合也不会产生这种效应,尽管它如预期那样产生了“血清素能综合征”。同样经外周给药的5-HT代谢前体5-羟色氨酸(5-HTP)的结果并不一致,在5毫克/千克和20毫克/千克时出现了遗忘效应,但在10毫克/千克时未出现。